Cornelius Miething

18PUBLICATIONS
150CO-AUTHORS
Tumour immunologyHaematological tumoursMedical infection agents (incl. prions)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 28, 2026
CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma.

|Mar 06, 2026
CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL.

Laura Polcik, Abhishek Pethe, Driti Ashok

|Feb 20, 2026
The FGFR1 N546K mutation confers resistance to pemigatinib in MLN-ZMYM2::FGFR1.

Khalid Shoumariyeh, Stefan Haug, Juliana Schwaab

|Jul 12, 2025
Modeling the t(2;5) Translocation of Anaplastic Large Cell Lymphoma Using CRISPR-Mediated Chromosomal Engineering.

Robin Khan, Laurent Phely, Sophia Ehrenfeld

|Jan 10, 2024
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease.

Kristina Maas-Bauer, Anna-Verena Stell, Kai-Li Yan

|Jan 25, 2023
Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms.

Amelie Jaeger, Sudheer Madan Mohan Gambheer, Xiaoyang Sun

Pageof 3

Frequent Collaborators

6 joint publications

Melanie Boerries

6 joint publications

Geoffroy Andrieux

5 joint publications

Robert Zeiser

5 joint publications

Justus Duyster